APA (7th ed.) Citation

D, E., S, J., J, D., N, E., M, d. B., M, A., . . . RF, S. (2025). Cardiometabolic outcomes with dapagliflozin after myocardial infarction by baseline ejection fraction: DAPA-MI. ESC heart failure, 12(6), 4184. https://doi.org/10.1002/ehf2.15420

Chicago Style (17th ed.) Citation

D, Erlinge, et al. "Cardiometabolic Outcomes with Dapagliflozin After Myocardial Infarction by Baseline Ejection Fraction: DAPA-MI." ESC Heart Failure 12, no. 6 (2025): 4184. https://doi.org/10.1002/ehf2.15420.

MLA (9th ed.) Citation

D, Erlinge, et al. "Cardiometabolic Outcomes with Dapagliflozin After Myocardial Infarction by Baseline Ejection Fraction: DAPA-MI." ESC Heart Failure, vol. 12, no. 6, 2025, p. 4184, https://doi.org/10.1002/ehf2.15420.